Reckitt Benckiser Group (LON:RB) had its price objective lifted by equities researchers at Goldman Sachs Group from GBX 6,910 ($96.89) to GBX 7,300 ($102.36) in a research note issued to investors on Wednesday. The firm currently has a “neutral” rating on the stock. Goldman Sachs Group’s price objective points to a potential upside of 13.88% from the company’s current price.

A number of other analysts also recently weighed in on RB. Morgan Stanley set a £100 ($140.21) target price on shares of Reckitt Benckiser Group and gave the company a “buy” rating in a research report on Wednesday, October 11th. Deutsche Bank reissued a “buy” rating and set a GBX 8,500 ($119.18) target price on shares of Reckitt Benckiser Group in a research report on Thursday, October 12th. Credit Suisse Group reissued an “outperform” rating and set a GBX 7,700 ($107.96) target price on shares of Reckitt Benckiser Group in a research report on Friday, October 13th. Whitman Howard reissued a “buy” rating and set a GBX 9,000 ($126.19) target price on shares of Reckitt Benckiser Group in a research report on Monday, October 16th. Finally, Liberum Capital reissued a “buy” rating and set a GBX 8,700 ($121.99) target price on shares of Reckitt Benckiser Group in a research report on Tuesday, October 17th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and ten have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of GBX 7,582.61 ($106.32).

Shares of Reckitt Benckiser Group (LON RB) opened at GBX 6,410 ($89.88) on Wednesday. The firm has a market cap of $45,040.00 and a P/E ratio of 2,143.81. Reckitt Benckiser Group has a 52-week low of GBX 6,299 ($88.32) and a 52-week high of GBX 8,110.43 ($113.72).

TRADEMARK VIOLATION NOTICE: This piece was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.dailypolitical.com/2018/02/09/reckitt-benckiser-group-rb-given-new-gbx-7300-price-target-at-goldman-sachs-group.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.